Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation

Serena Venturelli1, Simone Vasilij Benatti1, Monica Casati1

  • 1ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.

Insights

Long COVID symptoms persist in over half of recovered patients, including fatigue and breathing difficulties. A multidisciplinary approach is crucial for managing these complex post-COVID-19 conditions.

Area of Science:

  • Medicine
  • Public Health
  • Infectious Diseases

Background:

  • The Bergamo province was severely impacted by the COVID-19 pandemic.
  • A significant number of patients discharged from the hospital experienced persistent symptoms and psychological distress.

Purpose of the Study:

  • To evaluate the long-term health consequences of COVID-19 survivors.
  • To assess the effectiveness of a multidisciplinary follow-up program for COVID-19 patients.

Main Methods:

  • A public-funded, multidisciplinary follow-up program was established for COVID-19 patients.
  • 767 patients completed their first post-discharge assessment, a median of 81 days after discharge.

Main Results:

  • 51.4% of patients reported persistent symptoms like fatigue and exertional dyspnea.
  • 19% showed impaired lung diffusion, and 17% had elevated D-dimer levels, indicating potential pulmonary embolism.
  • 30.5% experienced post-traumatic psychological consequences.

Conclusions:

  • COVID-19 survivors face a complex range of persistent symptoms and psychological issues.
  • A multidisciplinary approach is essential for addressing the diverse needs of long COVID patients and finding effective treatments.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
603
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
117
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
747
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
518
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
606
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
897